155 results on '"Ibrahim, Joseph G."'
Search Results
2. New C‐indices for assessing importance of longitudinal biomarkers in fitting competing risks survival data in the presence of partially masked causes
3. The scale transformed power prior for use with historical data from a different outcome model
4. Synthesizing studies for comparing different treatment sequences in clinical trials
5. Estimating Cell Type Composition using Isoform Expression One Gene at a Time
6. On the normalized power prior
7. Efficient detection and classification of epigenomic changes under multiple conditions
8. Bayesian network meta‐regression hierarchical models using heavy‐tailed multivariate random effects with covariate‐dependent variances
9. Inferring latent heterogeneity using many feature variables supervised by survival outcome
10. A marginal estimate for the overall treatment effect on a survival outcome within the joint modeling framework
11. A hierarchical testing approach for detecting safety signals in clinical trials
12. Network meta‐regression for ordinal outcomes: Applications in comparing Crohn's disease treatments
13. Partial least squares for functional joint models with applications to the Alzheimer's disease neuroimaging initiative study
14. Joint analysis of single‐cell and bulk tissue sequencing data to infer intratumor heterogeneity
15. Bayesian design of biosimilars clinical programs involving multiple therapeutic indications
16. Global identifiability of latent class models with applications to diagnostic test accuracy studies: A Gröbner basis approach
17. A new Bayesian joint model for longitudinal count data with many zeros, intermittent missingness, and dropout with applications to HIV prevention trials
18. Semiparametric frailty models for zero‐inflated event count data in the presence of informative dropout
19. Controlling false discovery proportion in identification of drug‐related adverse events from multiple system organ classes
20. Hard thresholding regression
21. A practical Bayesian adaptive design incorporating data from historical controls
22. Bayesian design of a survival trial with a cured fraction using historical data
23. MILFM: Multiple index latent factor model based on high‐dimensional features
24. FLCRM: Functional linear cox regression model
25. Control-based imputation for sensitivity analyses in informative censoring for recurrent event data
26. Modeling event count data in the presence of informative dropout with application to bleeding and transfusion events in myelodysplastic syndrome
27. Pattern mixture models for clinical validation of biomarkers in the presence of missing data
28. Reply to Comments
29. Effective intra-S checkpoint responses to UVC in primary human melanocytes and melanoma cell lines
30. The power prior: theory and applications
31. In vivoassessment of the metabolic activity of CYP2D6 diplotypes and alleles
32. Responses to discussants of ‘Joint modeling of survival and longitudinal non‐survival data: current methods and issues. report of the DIA Bayesian joint modeling working group’
33. Hypothesis testing for two‐stage designs with over or under enrollment
34. Assessing temporal agreement between central and local progression-free survival times
35. DNA Damage Checkpoint Responses in the S Phase of Synchronized Diploid Human Fibroblasts
36. Bayesian probability of success for clinical trials using historical data
37. B ayesian Survival Analysis
38. B ayesian Approaches to Cure Rate Models
39. Bayesian Model Selection in Survival Analysis
40. Assessing model fit in joint models of longitudinal and survival data with applications to cancer clinical trials
41. Bayesian design of superiority clinical trials for recurrent events data with applications to bleeding and transfusion events in myelodyplastic syndrome
42. Joint modeling of longitudinal and survival data with missing and left-censored time-varying covariates
43. Joint modeling of survival and longitudinal non-survival data: current methods and issues. Report of the DIA Bayesian joint modeling working group
44. Mechanisms of chromosomal instability in melanoma
45. Bayesian sequential meta-analysis design in evaluating cardiovascular risk in a new antidiabetic drug development program
46. Cyclobutane Pyrimidine Dimer Density as a Predictive Biomarker of the Biological Effects of Ultraviolet Radiation in Normal Human Fibroblast
47. Bayesian Spatial Transformation Models with Applications in Neuroimaging Data
48. Use of historical control data for assessing treatment effects in clinical trials
49. Change-point models to estimate the limit of detection
50. Bayesian Transformation Models for Multivariate Survival Data
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.